News

IRIDEX Corp. launched a dual-port ophthalmic green laser photocoagulator (IQ 532) and a modular multi-wavelength laser photocoagulator at the recent annual meeting of the American Academy of Ophthalmology.

Topcon Medical Systems Inc. introduced a new image management and sharing software suite (EyeRoute) at the recent American Academy of Ophthalmology annual meeting.

Ellex Medical Lasers Ltd. unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology.

A major gift from an Omaha, NE, ophthalmologist will help fund construction of an eye institute at the University of Nebraska Medical Center (UNMC).

MacuSight has received fast-track designation from the FDA for its proprietary ocular sirolimus (Perceiva) product for the treatment of diabetic macular edema.

Abbott Laboratories has completed its acquisition of privately held eye-care company Visiogen, adding to its vision-care business an accommodating IOL technology (Synchrony) designed to address presbyopia in patients with cataracts.

The U.S. District Court for the District of Delaware has ruled in favor of Allergan Inc. in its patent infringement lawsuit against two sets of defendants seeking to market purported generic versions of the company?s formulations of brimonidine tartrate 0.1% and 0.15% (Alphagan P) for ocular hypertension and glaucoma. Specifically, the court ruled that Allergan's five patents related to the ophthalmic solutions are valid and enforceable.

Notal Vision has sold its clinic-based preferential hyperacuity perimeter (Foresee PHP) business to Reichert Ophthalmic Instruments.

"Through My Eyes: The Charlie Kelman Story," a 1-hour documentary about the ophthalmologist who developed the phacoemulsification technique of cataract removal, will premiere nationwide on public television Jan. 20, 2010, at 9 p.m.

J.C. Noreika, MD, MBA, submitted a letter to Sen. Sherrod Brown (D-OH), outlining nine possible unintended consequences to health-care reform.

Interim results from the first human pharmacokinetic study of an investigational extended-release intravitreal device for the treatment of diabetic macular edema suggest that it has both significant efficacy and a favorable side effect profile.

Practitioners seeking to minimize contrast sensitivity loss following panretinal photocoagulation in patients with diabetes may choose to consider performing PRP with a pattern scan laser system instead of a conventional argon laser.

Combination epimacular brachytherapy and anti-vascular endothelial growth factor therapy may help achieve and maintain optimal visual acuity outcomes over the long term in patients with neovascular age-related macular degeneration.

Results from a series of bench studies evaluating a new 25+-gauge vitrectomy proble and trocar system highlight the benefits and improved performance of this technology compared with previous instrumentation for microincision vitrectomy surgery.

Data analyses collected in a phase III clinical trial show a strong benefit of intravitreal ranibizumab for clearing macular edema and rehabilitating vision in patients who have suffered a branch retinal vein occlusion.

Blue laser autofluorescence has important clinical applications in the study of geographic atrophy and other retinal diseases.

Allergan is asking a federal judge to permit the company to talk freely with physicians regarding off-label use of Botox.

New data from phase III clinical trials of dexamethasone 0.7 mg intravitreal implant reaffirm that this novel pharmacotherapeutic intervention is well-tolerated and effectively improves vision in patients with macular edema secondary to a branch or central retinal vein occlusion.

Association mapping is a new perspective on the use of genomic tools that allows study of common disorders, such as diabetic retinopathy, and tries to tease apart genes as a way of studying disease pathophysiology.

Safety and efficacy analyses based on 6-month data collected in CRUISE phase III trial indicate a promising role of anti-vascular endothelial growth factor therapy with intravitreal ranibizumab in treatment of edema secondary to central retinal vein occlusion.

In this editorial, explore a discussion of meeting presentations on subjects rarely addressed by physicians in public.

New state-of-the-art wide-angle fundus imaging system offers vitreoretinal surgeons advantages of optical quality and improved workflow efficiency.

A new device for at-home monitoring of age-related macular degeneration is a promising tool for early detection of choroidal neovascularization.

Data continue to support intravitreal bevacizumab injection for treatment of radiation maculopathy and radiation optic neuropathy.

A new 577-nm solid-state laser allows retinal specialists to harness the benefits of yellow light for laser photocoagulation while providing a number of additional advantages.

A nationwide shortage of erythromycin ophthalmic ointment is causing some ophthalmologists to try alternative antibiotic therapies to treat superficial ocular infections.

Twice-daily dosing of bepostastine besilate ophthalmic solution 1.5% was found to be safe, with minimal adverse events, in a randomized, double-masked, 6-week safety study including two groups of healthy pediatric patients.

An interactive computer-based surgical teaching program is being developed as a training tool to provide users with the cognitive aspects of learning that are fundamental for developing expertise.